Device maker SonarMed ponders whether to go solo or find a partner
The Carmel-based company makes a device that uses sound waves to help position and monitor breathing tubes for newborns in hospitals.
Health Care & Life Sciences
Articles
Trump’s health subsidy shutdown could lead to free insurance
If President Donald Trump prevails in shutting down a major Obamacare health insurance subsidy, it could have the unintended consequence of making free basic coverage available to more people, and making upper-tier plans more affordable.
States ask U.S. court to keep up health subsidies cut by Trump
Top government lawyers representing 19 U.S. states on Wednesday asked a federal judge in California to force the administration of President Donald Trump to make health care subsidy payments that Trump abruptly cut off last week.
Anthem breaks with Express Scripts, to start own drug plan with CVS
Indianapolis-based insurer Anthem Inc. said it will set up its own pharmacy benefits management unit, signaling a final break with Express Scripts Holding Co. after the health insurer accused Express of overcharging it by billions of dollars.
Senators reach bipartisan deal to prop up Obamacare, keep subsidies
Senators in both political parties say they’ve reached agreement on fixes to stabilize Obamacare just two weeks before Americans start signing up for 2018 coverage.
Senators say they have outline of health insurance deal
Two leading senators said Tuesday they have the “basic outlines” of a bipartisan agreement to resume federal payments to health insurers that President Donald Trump has blocked.
Obamacare insurers, states rush to react to Trump’s latest move
Indianapolis-based Anthem Inc. declined to say Friday whether it would retreat even further from Obamacare than it already has in recent months.
Trump moving ‘step by step’ to take apart Obamacare on his own
Shares of publicly traded hospital chains including Tenet Healthcare Corp. slumped on Friday, as did insurers such as Centene Corp. and Anthem Inc.
Trump signs order to expand lower-cost, lower-benefit plans
Frustrated over setbacks in Congress, President Donald Trump wielded his rule-making power Thursday to launch an executive order that might get him closer to his goal of repealing and replacing Obamacare.
Express Scripts to buy medical test gatekeeper for $3.6B
The deal comes as Express Scripts faces challenges on a number of fronts, including the possible loss of its largest customer, Indianapolis-based health-insurance giant Anthem Inc.
IU announces $50M plan to tackle growing opioid epidemic
The university will hire 10 faculty members and team with the state and major health systems on what it calls a comprehensive plan to understand and deal with addictions, which are costing Indiana more than $1 billion a year.
Legal fight looms over California’s new drug pricing law
California has passed a law requiring pharmaceutical companies to explain their price increases, escalating the state-by-state battle between lawmakers trying to bring more transparency to the industry’s practices and drugmakers that oppose the efforts.
White House to order health care insurance alternatives
The White House is finalizing an executive order that would expand health plans offered by associations to allow individuals to pool together and buy insurance outside their states.
Zionsville pharmacist who put himself in feds’ sights admits to felonies
Harry Zhang pleaded guilty to two felonies this month after charged with illegally obtaining prescriptions from Canada and Germany and reselling them in China.
FDA approving drugs at accelerated pace
Thirty-four new drugs—treating everything from cancer to rare genetic diseases—have been approved so far this year. That’s on pace to nearly double last year’s approvals.
Trendy high-deductible health insurance plans lead patients to skip care
High-deductible health plans are booming in popularity, but, in an effort to save money, too many people are skipping preventive care even though such visits are covered 100 percent.
UPDATE: Indianapolis preparing to sue opioid makers, distributors
The city of Indianapolis plans to file a “robust lawsuit” against several drug companies, Mayor Joe Hogsett announced Thursday morning.
Struggling Endocyte spending millions for rights to prostate-cancer drug
After struggling for more than 20 years to develop cancer drugs without success, West Lafayette-based Endocyte Inc. is pausing it own R&D efforts to concentrate on a potential blockbuster drug from a German chemical company.
FDA approves Lilly drug for common advanced breast cancer
U.S. regulators have approved a new medicine for treating a common type of breast cancer after it has spread to other parts of the body.
FDA’s consumer protection warnings falling under Trump
From January to July, the agency sent 265 warning letters to companies, notifying them of what it alleged to be serious violations of federal rules. That’s the lowest tally for the first seven months of any year since 2008.